Trial Profile
Evaluation of PCV Schedules in a Naive Population in Vietnam
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary)
- Indications Pneumococcal infections; Pneumonia
- Focus Therapeutic Use
- 08 Jun 2021 Time frame for primary end-point is increased from 48 months to 60 months.
- 08 Jun 2021 Planned number of patients changed from 32400 to 45360.
- 08 Jun 2021 Planned End Date changed from 1 Dec 2020 to 31 Mar 2023.